Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

50.08
+0.85831.74%
Volume:6.58M
Turnover:327.31M
Market Cap:101.91B
PE:18.75
High:50.35
Open:50.19
Low:49.17
Close:49.22
Loading ...

Piper Sandler Adjusts Bristol-Myers Squibb's Price Target to $66 From $65

MT Newswires Live
·
Yesterday

Bristol-Myers' New Injection Version of Opdivo Gets UK Approval

MT Newswires Live
·
Yesterday

BRIEF-UK's MHRA Authorises Cancer Treatment Variation With An Administration Time Of 3–5 Minutes

Reuters
·
Yesterday

UK's Mhra: Approved New Under-the-Skin Injection Version of Nivolumab (Opdivo)

THOMSON REUTERS
·
Yesterday

UK's Mhra: Authorises Cancer Treatment Variation With an Administration Time of 3–5 Minutes - Website

THOMSON REUTERS
·
Yesterday

This High-Yield Pharma Stock Looks Like an Incredible Bargain

Motley Fool
·
Yesterday

Bristol-Myers Squibb Exec Makes Bold Stock Purchase!

TIPRANKS
·
Yesterday

Pfizer Reports Earnings as Stock Sits in Doldrums -- Barrons.com

Dow Jones
·
29 Apr

Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’

Insider Monkey
·
29 Apr

HSBC Adjusts Bristol-Myers Squibb Price Target to $47 From $56, Maintains Hold Rating

MT Newswires Live
·
28 Apr

BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?

Zacks
·
28 Apr

Bristol-Myers Squibb : HSBC Cuts Target Price to $47 From $56

THOMSON REUTERS
·
28 Apr

Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
26 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Merit Medical Systems (MMSI)

TIPRANKS
·
26 Apr

Market Chatter: Report Says 25% Pharma Tariff Would Raise US Drug Costs by $51 Billion Annually

MT Newswires Live
·
25 Apr

Report Says 25% Pharma Tariff Would Raise US Drug Prices by $51 Billion Annually, Reuters Reports

MT Newswires Live
·
25 Apr

BUZZ-Street View: Promising new frontiers ahead for Bristol Myers

Reuters
·
25 Apr

Bristol-Myers Squibb (BMY) Receives a Hold from Argus Research

TIPRANKS
·
25 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio

Insider Monkey
·
25 Apr